{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:37:24Z","timestamp":1794454644004,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Bisulfite conversion is considered the gold standard for DNA methylation analysis, but it damages DNA and performs sub-optimally with clinical samples (e.g., formalin-fixed paraffin-embedded and circulating free plasma DNA (cfDNA)). Here we describe a comprehensive comparison of bisulfite and enzymatic methylation sequencing, using commercially available assays in clinically relevant patient samples and cell lines. We also report the first clinical enzymatic whole genome methylation sequencing (WGMS) in a cohort of patients with chronic lymphocytic leukemia (CLL). We report data from a multi-arm experiment comprising controlled reference material and clinically relevant samples to assess technical differences between enzymatic and chemical methylation conversion technologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Enzymatic methylation sequencing was highly concordant to bisulfite data but outperformed bisulfite conversion in key sequencing metrics; the enzymatic method demonstrated significantly higher estimated counts of unique reads, reduced DNA fragmentation, and higher library yields than bisulfite conversion. Enzymatic conversion produced inferior methylation array data. Although bisulfite and enzymatic methods were highly concordant, the increased quality of multiple sequencing metrics seen in the enzymatic method enabled the development of robust clinical sample pipelines including targeted sequencing in cfDNA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Using the enzymatic methylation sequencing methods described, we report a putative link of interleukin (IL)-15 methylation changes to acalabrutinib treatment response in a CLL clinical trial cohort (ACE-CL-001 trial, NCT02029443).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13148-025-01959-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:10:37Z","timestamp":1759489837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples"],"prefix":"10.1186","volume":"17","author":[{"given":"Barrett","family":"Nuttall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrin","family":"Mendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cingolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Criscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhiy","family":"Naumenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bibikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerendra","family":"Munugalavadla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mortlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Carl Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Scaltriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hadfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"4","key":"1959_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1045","volume":"3","author":"PW Laird","year":"2003","unstructured":"Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3(4):253\u201366.","journal-title":"Nat Rev Cancer"},{"key":"1959_CR2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3389\/fgene.2019.01150","volume":"10","author":"WJ Locke","year":"2019","unstructured":"Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150.","journal-title":"Front Genet"},{"key":"1959_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4204","author":"EK Schutsky","year":"2018","unstructured":"Schutsky EK, DeNizio JE, Hu P, Liu MY, Nabel CS, Fabyanic EB, et al. Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase. Nat Biotechnol. 2018. https:\/\/doi.org\/10.1038\/nbt.4204.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1959_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41587-019-0041-2","volume":"37","author":"Y Liu","year":"2019","unstructured":"Liu Y, Siejka-Zieli\u0144ska P, Velikova G, Bi Y, Yuan F, Tomkova M, et al. Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol. 2019;37(4):424\u20139.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"1959_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1101\/gr.266551.120","volume":"31","author":"R Vaisvila","year":"2021","unstructured":"Vaisvila R, Ponnaluri VKC, Sun Z, Langhorst BW, Saleh L, Guan S, et al. Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res. 2021;31(7):1280\u20139.","journal-title":"Genome Res"},{"issue":"5","key":"1959_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","volume":"89","author":"M Frommer","year":"1992","unstructured":"Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89(5):1827\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1959_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nbt1010-1045","volume":"28","author":"BE Bernstein","year":"2010","unstructured":"Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol. 2010;28(10):1045\u20138.","journal-title":"Nat Biotechnol"},{"key":"1959_CR8","doi-asserted-by":"crossref","unstructured":"An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374.","DOI":"10.1038\/nature11247"},{"issue":"10","key":"1959_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"5","key":"1959_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2016.11.007","volume":"167","author":"HG Stunnenberg","year":"2016","unstructured":"Stunnenberg HG, Hirst M. The international human epigenome consortium: a blueprint for scientific collaboration and discovery. Cell. 2016;167(5):1145\u20139.","journal-title":"Cell"},{"issue":"7","key":"1959_CR11","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.bmcl.2007.01.040","volume":"17","author":"K Tanaka","year":"2007","unstructured":"Tanaka K, Okamoto A. Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett. 2007;17(7):1912\u20135.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"1959_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cell.2008.03.029","volume":"133","author":"R Lister","year":"2008","unstructured":"Lister R, O\u2019Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell. 2008;133(3):523\u201336.","journal-title":"Cell"},{"issue":"7184","key":"1959_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature06745","volume":"452","author":"SJ Cokus","year":"2008","unstructured":"Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature. 2008;452(7184):215\u20139.","journal-title":"Nature"},{"issue":"10","key":"1959_CR14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nbt.1681","volume":"28","author":"C Bock","year":"2010","unstructured":"Bock C, Tomazou EM, Brinkman AB, M\u00fcller F, Simmer F, Gu H, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol. 2010;28(10):1106\u201314.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"1959_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199091","volume":"13","author":"S Kint","year":"2018","unstructured":"Kint S, De Spiegelaere W, De Kesel J, Vandekerckhove L, Van Criekinge W. Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR. PLoS ONE. 2018;13(6): e0199091.","journal-title":"PLoS ONE"},{"issue":"1","key":"1959_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13059-018-1408-2","volume":"19","author":"N Olova","year":"2018","unstructured":"Olova N, Krueger F, Andrews S, Oxley D, Berrens RV, Branco MR, et al. Comparison of whole-genome bisulfite sequencing library preparation strategies identifies sources of biases affecting DNA methylation data. Genome Biol. 2018;19(1):33.","journal-title":"Genome Biol"},{"issue":"1","key":"1959_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17(1):208.","journal-title":"Genome Biol"},{"issue":"11","key":"1959_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis M, Heath S, Bibikova M, Queir\u00f3s AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236\u201342.","journal-title":"Nat Genet"},{"issue":"1","key":"1959_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/leu.2012.245","volume":"27","author":"N Cahill","year":"2013","unstructured":"Cahill N, Bergh AC, Kanduri M, G\u00f6ransson-Kultima H, Mansouri L, Isaksson A, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia. 2013;27(1):150\u20138.","journal-title":"Leukemia"},{"issue":"6","key":"1959_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","volume":"26","author":"DA Landau","year":"2014","unstructured":"Landau DA, Clement K, Ziller MJ, Boyle P, Fan J, Gu H, et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell. 2014;26(6):813\u201325.","journal-title":"Cancer Cell"},{"issue":"8","key":"1959_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood.2019000490","volume":"134","author":"B Giacopelli","year":"2019","unstructured":"Giacopelli B, Zhao Q, Ruppert AS, Agyeman A, Weigel C, Wu YZ, et al. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. Blood. 2019;134(8):688\u201398.","journal-title":"Blood"},{"issue":"3","key":"1959_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet. 2016;48(3):253\u201364.","journal-title":"Nat Genet"},{"issue":"6","key":"1959_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","volume":"24","author":"R Beekman","year":"2018","unstructured":"Beekman R, Chapaprieta V, Russi\u00f1ol N, Vilarrasa-Blasi R, Verdaguer-Dot N, Martens JHA, et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat Med. 2018;24(6):868\u201380.","journal-title":"Nat Med"},{"issue":"1","key":"1959_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41597-020-0456-0","volume":"7","author":"DY Yosifov","year":"2020","unstructured":"Yosifov DY, Bloehdorn J, D\u00f6hner H, Lichter P, Stilgenbauer S, Mertens D. DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy. Sci Data. 2020;7(1):133.","journal-title":"Sci Data"},{"issue":"1","key":"1959_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0783-1","volume":"11","author":"M Tsagiopoulou","year":"2019","unstructured":"Tsagiopoulou M, Papakonstantinou N, Moysiadis T, Mansouri L, Ljungstr\u00f6m V, Duran-Ferrer M, et al. DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy. Clin Epigenetics. 2019;11(1): 177.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"1959_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1509981","volume":"374","author":"JC Byrd","year":"2016","unstructured":"Byrd JC, Harrington B, O\u2019Brien S, Jones JA, Schuh A, Devereux S, et al. Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia. N Engl J Med. 2016;374(4):323\u201332.","journal-title":"N Engl J Med"},{"issue":"5","key":"1959_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41389-019-0142-2","volume":"8","author":"KB Holmes","year":"2019","unstructured":"Holmes KB, Sadreev II, Rawstron AC, Munir T, Westhead DR, Hillmen P, et al. Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells. Oncogenesis. 2019;8(5):32.","journal-title":"Oncogenesis"},{"issue":"15","key":"1959_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1182\/blood.2018884940","volume":"135","author":"JC Byrd","year":"2020","unstructured":"Byrd JC, Wierda WG, Schuh A, Devereux S, Chaves JM, Brown JR, et al. Acalabrutinib monotherapy in patients with relapsed\/refractory chronic lymphocytic leukemia: updated phase 2 results. Blood. 2020;135(15):1204\u201313.","journal-title":"Blood"},{"issue":"7818","key":"1959_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh N, Adrian J, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583(7818):699\u2013710.","journal-title":"Nature"},{"issue":"7345","key":"1959_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature09881","volume":"473","author":"MM Winslow","year":"2011","unstructured":"Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 2011;473(7345):101\u20134.","journal-title":"Nature"},{"issue":"2","key":"1959_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2013.02.018","volume":"50","author":"EL Snyder","year":"2013","unstructured":"Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, et al. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol Cell. 2013;50(2):185\u201399.","journal-title":"Mol Cell"},{"issue":"2","key":"1959_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood-2007-04-087882","volume":"111","author":"D de Totero","year":"2008","unstructured":"de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, Balleari E, et al. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK\/STAT and ERK1\/2 pathways. Blood. 2008;111(2):517\u201324.","journal-title":"Blood"},{"issue":"98","key":"1959_CR33","doi-asserted-by":"publisher","first-page":"37173","DOI":"10.18632\/oncotarget.26444","volume":"9","author":"S Sinha","year":"2018","unstructured":"Sinha S, Boysen JC, Chaffee KG, Kabat BF, Slager SL, Parikh SA, et al. Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy. Oncotarget. 2018;9(98):37173\u201384.","journal-title":"Oncotarget"},{"issue":"10","key":"1959_CR34","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.4049\/jimmunol.1801142","volume":"202","author":"R Gupta","year":"2019","unstructured":"Gupta R, Li W, Yan XJ, Barrientos J, Kolitz JE, Allen SL, et al. Mechanism for IL-15-driven B cell chronic lymphocytic leukemia cycling: roles for AKT and STAT5 in modulating cyclin D2 and DNA damage response proteins. J Immunol. 2019;202(10):2924\u201344.","journal-title":"J Immunol"},{"issue":"2","key":"1959_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41408-021-00429-z","volume":"11","author":"P Lu","year":"2021","unstructured":"Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, et al. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021;11(2):39.","journal-title":"Blood Cancer J"},{"issue":"6","key":"1959_CR36","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1111\/cas.14905","volume":"112","author":"Y Kagiyama","year":"2021","unstructured":"Kagiyama Y, Fujita S, Shima Y, Yamagata K, Katsumoto T, Nakagawa M, et al. CDKN1C-mediated growth inhibition by an EZH1\/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Cancer Sci. 2021;112(6):2314\u201324.","journal-title":"Cancer Sci"},{"issue":"1","key":"1959_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13072-021-00401-y","volume":"14","author":"J Morrison","year":"2021","unstructured":"Morrison J, Koeman JM, Johnson BK, Foy KK, Beddows I, Zhou W, et al. Evaluation of whole-genome DNA methylation sequencing library preparation protocols. Epigenetics Chromatin. 2021;14(1):28.","journal-title":"Epigenetics Chromatin"},{"issue":"17","key":"1959_CR38","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1093\/nar\/gks454","volume":"40","author":"F Miura","year":"2012","unstructured":"Miura F, Enomoto Y, Dairiki R, Ito T. Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging. Nucleic Acids Res. 2012;40(17):e136.","journal-title":"Nucleic Acids Res"},{"issue":"6880","key":"1959_CR39","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/416552a","volume":"416","author":"I Rhee","year":"2002","unstructured":"Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416(6880):552\u20136.","journal-title":"Nature"},{"issue":"1","key":"1959_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13059-021-02529-2","volume":"22","author":"J Foox","year":"2021","unstructured":"Foox J, Nordlund J, Lalancette C, Gong T, Lacey M, Lent S, et al. The SEQC2 epigenomics quality control (EpiQC) study. Genome Biol. 2021;22(1):332.","journal-title":"Genome Biol"},{"key":"1959_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.25","volume":"3","author":"JM Zook","year":"2016","unstructured":"Zook JM, Catoe D, McDaniel J, Vang L, Spies N, Sidow A, et al. Extensive sequencing of seven human genomes to characterize benchmark reference materials. Sci Data. 2016;3: 160025.","journal-title":"Sci Data"},{"key":"1959_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nmeth.4184","volume":"14","author":"J Simpson","year":"2017","unstructured":"Simpson J, Workman R, Zuzarte P, et al. Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods. 2017;14:407\u201310.","journal-title":"Nat Methods"},{"issue":"4","key":"1959_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nmeth.4189","volume":"14","author":"A Rand","year":"2017","unstructured":"Rand A, Jain M, Eizenga J, et al. Mapping DNA methylation with high-throughput nanopore sequencing. Nat Methods. 2017;14(4):411\u20133.","journal-title":"Nat Methods"},{"key":"1959_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-024-03207-9","volume":"25","author":"BD Sigurpalsdottir","year":"2024","unstructured":"Sigurpalsdottir BD, Stefansson OA, Holley G, et al. A comparison of methods for detecting DNA methylation from long-read sequencing of human genomes. Genome Biol. 2024;25:69.","journal-title":"Genome Biol"},{"key":"1959_CR45","doi-asserted-by":"publisher","unstructured":"O\u2019Neill K, Pleasance E, Fan J, Akbari V, Chang G, Dixon K et al. Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes. medRxiv. 2024. doi.org\/https:\/\/doi.org\/10.1101\/2024.02.20.24302959","DOI":"10.1101\/2024.02.20.24302959"},{"key":"1959_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-023-01178-3","volume":"15","author":"BT Lau","year":"2023","unstructured":"Lau BT, Almeda A, Schauer M, et al. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. Genome Med. 2023;15:33.","journal-title":"Genome Med"},{"issue":"6","key":"1959_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31(6):745\u201359.","journal-title":"Ann Oncol"},{"issue":"1","key":"1959_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0710-5","volume":"11","author":"EJ Rodger","year":"2019","unstructured":"Rodger EJ, Chatterjee A, Stockwell PA, Eccles MR. Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types. Clin Epigenetics. 2019;11(1): 114.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"1959_CR49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/leu.2013.358","volume":"28","author":"S Cheng","year":"2014","unstructured":"Cheng S, Ma J, Guo A, Lu P, Leonard JP, Coleman M, et al. BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity. Leukemia. 2014;28(3):649\u201357.","journal-title":"Leukemia"},{"key":"1959_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2016.05.003","volume":"47","author":"D Manzoni","year":"2016","unstructured":"Manzoni D, Catallo R, Chebel A, Baseggio L, Michallet AS, Roualdes O, et al. The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: application to chronic lymphocytic leukemia. Leuk Res. 2016;47:1\u20137.","journal-title":"Leuk Res"},{"issue":"14","key":"1959_CR51","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1021\/acs.jmedchem.7b00485","volume":"60","author":"A Qu\u00e9m\u00e9ner","year":"2017","unstructured":"Qu\u00e9m\u00e9ner A, Maillasson M, Arzel L, Sicard B, Vomiandry R, Mortier E, et al. Discovery of a small-molecule inhibitor of interleukin 15: pharmacophore-based virtual screening and hit optimization. J Med Chem. 2017;60(14):6249\u201372.","journal-title":"J Med Chem"},{"issue":"11","key":"1959_CR52","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27(11):1571\u20132.","journal-title":"Bioinformatics"},{"issue":"4","key":"1959_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"key":"1959_CR54","unstructured":"Pedersen BS, Eyring K, De S, Yang IV, Schwartz DA. Fast and accurate alignment of long bisulfite-seqreads. Bioinformatics. 2005:1\u20132."},{"key":"1959_CR55","unstructured":"MethylDackel: GitHub, Inc.; 2023 [Available from: https:\/\/github.com\/dpryan79\/MethylDackel."},{"key":"1959_CR56","unstructured":"Smit A, Hubley R, Green P. RepeatMasker Open-4.0: National Human Genome Research Institute; [Available from: https:\/\/www.repeatmasker.org\/."},{"issue":"W1","key":"1959_CR57","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez F, Ryan DP, Gr\u00fcning B, Bhardwaj V, Kilpert F, Richter AS, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44(W1):W160\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1959_CR58","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, et al. OncoKB: A Precision Oncology Knowledge Base. JCO Precis Oncol. 2017;2017."},{"issue":"3","key":"1959_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, et al. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17(3):251\u201364.","journal-title":"J Mol Diagn"},{"issue":"13 Supplement","key":"1959_CR60","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1158\/1538-7445.AM2019-3409","volume":"79","author":"RN Ptashkin","year":"2019","unstructured":"Ptashkin RN, Benayed R, Ziegler J, Rema AB, Sadowska J, Kiecka I, et al. MSK-IMPACT Heme: Validation and clinical experience of a comprehensive molecular profiling platform for hematologic malignancies [abstract 3409]. Cancer Res. 2019;79(13 Supplement):3409.","journal-title":"Cancer Res"},{"issue":"11","key":"1959_CR61","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023\u201331.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1959_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237802","volume":"15","author":"R Woodhouse","year":"2020","unstructured":"Woodhouse R, Li M, Hughes J, Delfosse D, Skoletsky J, Ma P, et al. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS ONE. 2020;15(9): e0237802.","journal-title":"PLoS ONE"},{"issue":"6127","key":"1959_CR63","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546\u201358.","journal-title":"Science"},{"issue":"D1","key":"1959_CR64","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019;47(D1):D941\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1959_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence M, Huber W, Pag\u00e8s H, Aboyoun P, Carlson M, Gentleman R, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol. 2013;9(8): e1003118.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1959_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"key":"1959_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, Melnick A, Mason CE. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 2012;13: R87.","journal-title":"Genome Biol"},{"issue":"10","key":"1959_CR68","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"4","key":"1959_CR69","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558\u201360.","journal-title":"Bioinformatics"},{"issue":"4","key":"1959_CR70","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.4.894","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of infinium DNA methylation beadchip probes. Nucleic Acids Res. 2017;45(4): e22.","journal-title":"Nucleic Acids Res"},{"key":"1959_CR71","doi-asserted-by":"crossref","unstructured":"Chen, Y. an, Lemire, M., Choufani, S., Butcher, D. T., Grafodatskaya, D., Zanke, B. W., et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray.\u00a0Epigenetics,\u00a02013; 8(2):203\u2013209.","DOI":"10.4161\/epi.23470"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01959-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:03:55Z","timestamp":1759493035000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01959-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01959-0","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BN, DLK, KB, MC, KM, PC, SC, SN, EB, VM, AM, BD, JCB, MS and JH are or were AstraZeneca employees and shareholders. JCB, RRF, and JRB declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}